| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000035547 |
| Receipt No. | R000040324 |
| Official scientific title of the study | Effects of Kampo formula on oxidative stress |
| Date of disclosure of the study information | 2019/02/01 |
| Last modified on | 2019/01/15 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Effects of Kampo formula on oxidative stress | |
| Title of the study (Brief title) | Kampo and oxidative stress | |
| Region |
|
|
| Condition | |||
| Condition | Patients who receives Kampo formula treatments | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | In this study, we evaluate the effect of Kampo, Japanese traditional herbal medicine, on oxidative stress using state-of-the-art technology using patients samples ex vivo, and analyze the relationship with the pathophysiological status. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Oxidative stress marker (MULTIS) |
| Key secondary outcomes | Oxidative stress and inflammation markers: iStrap, IL-6, TNF-a, adiponectin, CRP |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patient diagnosed as "Sho (pattern)" to the corresponding Kampo formula.
2. Patient newly treated with the corresponding Kampo formula for more than 12 weeks. 3. Patients who showed consent to this research. Kampo: Go-sha-jinki-Gan, Hachimi-jio-Gan, Saiko-ka-ryukotsu-borei-To, Oren-gedoku-To, Keishi-bukuryo-Gan, Toki-shakuyaku-San, Saiko-keishi-kankyo-To, Kami-kihi-To. |
|||
| Key exclusion criteria | 1. Those who can not obtain consent to participate in research.
2. Those who can not express self-will 3. Those judged to be inappropriate by the researchers or research sharing doctor 4. Those who already medicated with Kampo formulation(s) constantly, and change(s) or addition(s) of new Kampo formulation(s) are made within the two weeks before the start of this investigation. |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Aki Hirayama |
| Organization | Tsukuba University of Technology |
| Division name | Center for Integrative Medicine |
| Address | 4-12-7 Kasuga, Tsukuba, Japan |
| TEL | 0298589590 |
| aki-hira@k.tsukuba-tech.ac.jp | |
| Public contact | |
| Name of contact person | Aki Hirayama |
| Organization | Tsukuba University of Technology |
| Division name | Center for Integrative Medicine |
| Address | 4-12-7 Kasuga, Tsukuba, Japan |
| TEL | 0298589590 |
| Homepage URL | |
| aki-hira@k.tsukuba-tech.ac.jp | |
| Sponsor | |
| Institute | Center for Integrative Medicine
Tsukuba University of Technology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tsukuba University of Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 筑波技術大学東西医学統合医療センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Observation
Oxidative stress markers; (MULTIS, iStrap, 8-OHdG, IL-6, adiponectin), Clinical information (history, clinical examination results). |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040324 |